Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
Calvin Skelton was unsure how he wanted to tell his players that he planned to retire after this season. He could wait until the year ended, but felt they deserved more notice. He could tell them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results